Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

?hemiluminescent activity of blood phagocytes in patients with covid-19

Anna Lazareva, Oksana Kolenchukova, Svetlana Smirnova, Victorya Melder, Sergey Tereshchenko
European Respiratory Journal 2021 58: PA3878; DOI: 10.1183/13993003.congress-2021.PA3878
Anna Lazareva
1Institute for Medical Problems of the North, Federal Research Center of the KSC SB RAS, Krasnoyarsk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nuraaa@rambler.ru
Oksana Kolenchukova
2Institute for Medical Problems of the North, Federal Research Center of the KSC SB RAS, Siberian Federal University, Krasnoyarsk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Svetlana Smirnova
1Institute for Medical Problems of the North, Federal Research Center of the KSC SB RAS, Krasnoyarsk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victorya Melder
3Siberian Federal University, Krasnoyarsk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sergey Tereshchenko
1Institute for Medical Problems of the North, Federal Research Center of the KSC SB RAS, Krasnoyarsk, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

The number of people infected with COVID-19 around the world is steadily increasing. COVID-19 is a new respiratory infection. The causative agent of the disease, a new RNA-containing coronavirus SARS-CoV2, was discovered at the end of 2019.

Objective: To assess the functional activity of blood phagocytes in patients with COV19.

Objects: patients with cov19 (n = 33); control(n = 36). The diagnosis of COV19 was made on the basis of a positive PCR test (nasal swab) and an ELISA method for the presence of M and G antibodies in the blood serum using Architect SARS-CoV-2 IgGandAdviseDx SARS-CoV-2 IgM test systems (Architect).

Methods: Phagocytes (neutrophilic granulocytes and monocytes) were isolated from peripheral blood in a double density gradient ficoll-urografin (1.077; 1.17 g/cm3). Mononuclear cells were adhered to plastic. Functional activity was measured using luminol and lucigenin-dependent chemiluminescence. The basic and reserve activity (upon induction with zymosan) was determined. The parameters were investigated: time to peak (Tmax), intensity (Imax) and area under the curve (Smax), activation index (IA).

Results: The study of phagocytes showed a decrease in Imax (p=0.03), Tmax (p<0.001), Smax (p=0.02) and IA (p<0.001) of the baseline and induced luminol-dependent response relative to the control. In the lucigenin-dependent chemiluminescence of neutrophilic granulocytes, an increase in the Tmax of the baseline and induced responses (p<0.001) is observed, with a decrease in Imax, Smax and IA. In monocytes, there is a decrease in Tmax, Imax, Smax and AI of the chemiluminescent process (p =0.02; р=0.01) relative to the control.

  • Covid-19
  • Adults
  • Monocyte / Macrophage

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3878.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
?hemiluminescent activity of blood phagocytes in patients with covid-19
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
?hemiluminescent activity of blood phagocytes in patients with covid-19
Anna Lazareva, Oksana Kolenchukova, Svetlana Smirnova, Victorya Melder, Sergey Tereshchenko
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3878; DOI: 10.1183/13993003.congress-2021.PA3878

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
?hemiluminescent activity of blood phagocytes in patients with covid-19
Anna Lazareva, Oksana Kolenchukova, Svetlana Smirnova, Victorya Melder, Sergey Tereshchenko
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3878; DOI: 10.1183/13993003.congress-2021.PA3878
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Laboratory, functional and imaging changes in the follow-up of hospitalized patients with COVID 19
  • CT patterns of lung damage and prognosis markers for the course of a new coronavirus infection COVID-19 in persons with comorbidity
  • Impact of Covid-19 Pneumonia on Pulmonary Function, Functional Exercise Capacity and Quality of Life
Show more Clinical problems

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society